Enabling Counterfactual Survival Analysis with Balanced Representations

• URL: http://arxiv.org/abs/2006.07756v2
• Date: Wed, 3 Mar 2021 16:32:20 GMT
• Title: Enabling Counterfactual Survival Analysis with Balanced Representations
• Authors: Paidamoyo Chapfuwa, Serge Assaad, Shuxi Zeng, Michael J. Pencina, Lawrence Carin, Ricardo Henao
• Abstract summary: Survival data are frequently encountered across diverse medical applications, i.e., drug development, risk profiling, and clinical trials. We propose a theoretically grounded unified framework for counterfactual inference applicable to survival outcomes.
• Score: 64.17342727357618
• License: http://creativecommons.org/licenses/by-nc-sa/4.0/
• Abstract: Balanced representation learning methods have been applied successfully to counterfactual inference from observational data. However, approaches that account for survival outcomes are relatively limited. Survival data are frequently encountered across diverse medical applications, i.e., drug development, risk profiling, and clinical trials, and such data are also relevant in fields like manufacturing (e.g., for equipment monitoring). When the outcome of interest is a time-to-event, special precautions for handling censored events need to be taken, as ignoring censored outcomes may lead to biased estimates. We propose a theoretically grounded unified framework for counterfactual inference applicable to survival outcomes. Further, we formulate a nonparametric hazard ratio metric for evaluating average and individualized treatment effects. Experimental results on real-world and semi-synthetic datasets, the latter of which we introduce, demonstrate that the proposed approach significantly outperforms competitive alternatives in both survival-outcome prediction and treatment-effect estimation.

Related papers

• Estimating Individual Dose-Response Curves under Unobserved Confounders from Observational Data [6.166869525631879]
  We present ContiVAE, a novel framework for estimating causal effects of continuous treatments, measured by individual dose-response curves. We show that ContiVAE outperforms existing methods by up to 62%, demonstrating its robustness and flexibility.
  arXiv  Detail & Related papers  (2024-10-21T07:24:26Z)
• A Double Machine Learning Approach to Combining Experimental and Observational Data [59.29868677652324]
  We propose a double machine learning approach to combine experimental and observational studies. Our framework tests for violations of external validity and ignorability under milder assumptions.
  arXiv  Detail & Related papers  (2023-07-04T02:53:11Z)
• Recovering Sparse and Interpretable Subgroups with Heterogeneous Treatment Effects with Censored Time-to-Event Outcomes [14.928328404160299]
  We propose a statistical approach to recovering sparse phenogroups (or subtypes) that demonstrate differential treatment effects as compared to the study population. We propose a novel inference procedure for the proposed model and demonstrate its efficacy in recovering sparse phenotypes across large landmark real world clinical studies in cardiovascular health.
  arXiv  Detail & Related papers  (2023-02-24T08:10:23Z)
• SurvCaus : Representation Balancing for Survival Causal Inference [3.4161707164978137]
  In many pathologies, the outcome of interest is a (possibly censored) survival time. Our paper proposes theoretical guarantees for a representation balancing framework applied to counterfactual inference in a survival setting.
  arXiv  Detail & Related papers  (2022-03-29T15:33:55Z)
• SurvITE: Learning Heterogeneous Treatment Effects from Time-to-Event Data [83.50281440043241]
  We study the problem of inferring heterogeneous treatment effects from time-to-event data. We propose a novel deep learning method for treatment-specific hazard estimation based on balancing representations.
  arXiv  Detail & Related papers  (2021-10-26T20:13:17Z)
• Double Robust Representation Learning for Counterfactual Prediction [68.78210173955001]
  We propose a novel scalable method to learn double-robust representations for counterfactual predictions. We make robust and efficient counterfactual predictions for both individual and average treatment effects. The algorithm shows competitive performance with the state-of-the-art on real world and synthetic data.
  arXiv  Detail & Related papers  (2020-10-15T16:39:26Z)
• A standardized framework for risk-based assessment of treatment effect heterogeneity in observational healthcare databases [60.07352590494571]
  The aim of this study was to extend this approach to the observational setting using a standardized scalable framework. We demonstrate our framework by evaluating the effect of angiotensin-converting enzyme (ACE) inhibitors versus beta blockers on three efficacy and six safety outcomes.
  arXiv  Detail & Related papers  (2020-10-13T14:48:31Z)
• Conformal Inference of Counterfactuals and Individual Treatment Effects [6.810856082577402]
  We propose a conformal inference-based approach that can produce reliable interval estimates for counterfactuals and individual treatment effects. Existing methods suffer from a significant coverage deficit even in simple models.
  arXiv  Detail & Related papers  (2020-06-11T01:03:32Z)
• Generalization Bounds and Representation Learning for Estimation of Potential Outcomes and Causal Effects [61.03579766573421]
  We study estimation of individual-level causal effects, such as a single patient's response to alternative medication. We devise representation learning algorithms that minimize our bound, by regularizing the representation's induced treatment group distance. We extend these algorithms to simultaneously learn a weighted representation to further reduce treatment group distances.
  arXiv  Detail & Related papers  (2020-01-21T10:16:33Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.